Search - tctmd.com

Displaying 21 - 40 of 701

Sort: Relevancy | Date

Presentation NY Valves 2025

Anatomic Correlation Between Noninvasive and Invasive Angiogram on the Use of Cerebral Embolic Protection Devices in TAVR: A Real-world Experience From a Single Tertiary Care Center

Presenter: Bhavanadhar Penta

June 27, 2025

Presentation NY Valves 2025

Stroke and Cerebral Embolic Protection Devices in Contemporary TAVR Practice

Presenter: Alexandra J. Lansky

June 26, 2025

Presentation NY Valves 2025

Featured Research: A Prospective, Single-Arm, Multicenter Feasibility Trial to Evaluate the Safety and Performance of the F2 Filter and Delivery System Used for Embolic Protection During TAVR

Presenter: Robert Gooley

June 25, 2025

Presentation NY Valves 2025

Technology and Clinical Update: Aortic Capture and Removal Filters

Presenter: Tamim M. Nazif

June 25, 2025

Presentation NY Valves 2025

Technology and Clinical Update: Arch Deflector Devices

Presenter: Giora Weisz

June 25, 2025

Presentation NY Valves 2025

Untangling The Knot: Defining Appropriate Clinical Trial Endpoints and the Path Forward

Presenter: Alexandra J. Lansky

June 25, 2025

Presentation NY Valves 2025

Updates from the Sentinel Clinical Trial Program: PROTECTED TAVR and BHF PROTECT-TAVI Meta-Analysis

Presenter: Samir R. Kapadia

June 25, 2025

Presentation NY Valves 2025

Latest Clinical Insights: Bridging Evidence and Practice

Presenter: Samir R. Kapadia

June 25, 2025

Presentation NY Valves 2025

Efficacy of CEP Devices to Reduce Stroke during TAVR: Insights From the TVT Registry

Presenter: David J. Cohen

June 25, 2025

Presentation NY Valves 2025

Mitigating Stroke Risk in TAVR: Global Burden and the Role of Embolic Protection

Presenter: Suzanne J. Baron

June 25, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2025

Caitlin E. Cox

May 30, 2025

News Conference News EuroPCR 2025

Meta-analysis Quashes Hopes for Routine Embolic Protection in TAVI

Michael O'Riordan

May 21, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2025

Caitlin E. Cox

April 30, 2025

News Conference News ACC 2025

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

Michael O'Riordan

April 02, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2025

Caitlin E. Cox

April 01, 2025

News Conference News ACC 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Michael O'Riordan

March 30, 2025

News Conference News ACC 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Caitlin E. Cox

March 29, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Daily News

Embolic Protection Use During TAVI Declined After PROTECTED TAVR

Todd Neale

March 21, 2025

News Daily News

Biomarker-Based Risk Score Better Predicts Stroke in AF Than Clinical Tools

Todd Neale

March 19, 2025

Advertisement

Anatomic Correlation Between Noninvasive and Invasive Angiogram on the Use of Cerebral Embolic Protection Devices in TAVR: A Real-world Experience From a Single Tertiary Care Center

Stroke and Cerebral Embolic Protection Devices in Contemporary TAVR Practice

Featured Research: A Prospective, Single-Arm, Multicenter Feasibility Trial to Evaluate the Safety and Performance of the F2 Filter and Delivery System Used for Embolic Protection During TAVR

Technology and Clinical Update: Aortic Capture and Removal Filters

Technology and Clinical Update: Arch Deflector Devices

Untangling The Knot: Defining Appropriate Clinical Trial Endpoints and the Path Forward

Updates from the Sentinel Clinical Trial Program: PROTECTED TAVR and BHF PROTECT-TAVI Meta-Analysis

Latest Clinical Insights: Bridging Evidence and Practice

Efficacy of CEP Devices to Reduce Stroke during TAVR: Insights From the TVT Registry

Mitigating Stroke Risk in TAVR: Global Burden and the Role of Embolic Protection

TCTMD’s Top 10 Most Popular Stories for May 2025

Meta-analysis Quashes Hopes for Routine Embolic Protection in TAVI

TCTMD’s Top 10 Most Popular Stories for April 2025

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

TCTMD’s Top 10 Most Popular Stories for March 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

What’s Going to Be Hot at ACC 2025?

Embolic Protection Use During TAVI Declined After PROTECTED TAVR

Biomarker-Based Risk Score Better Predicts Stroke in AF Than Clinical Tools

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content